The Patent Finder

Terms ending in 2038

Actelion Pharmaceuticals Ltd

Every in-force patent on Actelion Pharmaceuticals Ltd's record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US D974,921Pharmaceutical Package
In force
 · High confidence
Vanda Pharmaceuticals Inc.In forceHigh confidence
US 10,899,695A Novel Process for the Synthesis of 1-ARYL-1-Trifluoromethylcyclopropanes
In force
 · High confidence
Idorsia Pharmaceuticals Ltd.In forceHigh confidence
US 10,919,881Crystalline Forms of a 4-Pyrimidinesulfamide Derivative Aprocitentan
In force
 · High confidence
Idorsia Pharmaceuticals Ltd.In forceHigh confidence
US 12,297,189Crystalline Forms of a 4-Pyrimidinesulfamide Derivative Aprocitentan
In force
 · Low confidence
Idorsia Pharmaceuticals Ltd.In forceLow confidence
US 11,787,782Combinations of a 4-Pyrimidinesulfamide Derivative with Active Ingredients for the Treatment of Endothelin Related Diseases
In force
 · Medium confidence
Idorsia Pharmaceuticals Ltd.In forceMedium confidence
US 11,179,390Subcutaneous Administration of a P2Y12 Receptor Antagonist
In force
 · High confidence
Viatris Asia Pacific Pte. Ltd.In forceHigh confidence
US 11,713,297Crystalline Form of N-Butyldeoxygalactonojirimycin
In force
 · High confidence
Idorsia Pharmaceuticals Ltd.In forceHigh confidence
US 11,124,488Preparation of 2-([1,2,3]TRIAZOL-2-YL)-BENZOIC Acid Derivatives
In force
 · High confidence
Idorsia Pharmaceuticals Ltd.In forceHigh confidence
US 11,723,896Pharmaceutical Combination Comprising Ponesimod
In force
 · High confidence
Vanda Pharmaceuticals Inc.In forceHigh confidence
US 11,446,298Pyrimidine Derivatives
In force
 · High confidence
Idorsia Pharmaceuticals Ltd.In forceHigh confidence
6 more term ends in 2038 · Pro
10 of 16 patents shown. Soonest term end first, then patent number.
Pro members see all 16.
Upgrade to Pro
1 of these is in force and held by Actelion Pharmaceuticals Ltd.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited